Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands
Authors:
- Enrique RaviñaEREnrique Raviña
- Christian F. MasaguerCMChristian F. Masaguer
- Filipe AreiasFAFilipe Areias
- José BreaJBJosé Brea
- María I. LozaMLMaría I. Loza
- Jana SelentJSJana Selent
- Manuel PastorManuel Pastor
- Ferran SanzFSFerran Sanz
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (6) , 1773-1778
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Dopamine D3 receptor antagonists as therapeutic agentsDrug Discovery Today, 2005
- Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophreniaNature Reviews Drug Discovery, 2004
- Half a century of antipsychotics and still a central role for dopamine D2 receptorsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockadeNeuropharmacology, 2003
- Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugsPharmacology & Therapeutics, 2001
- The D 3 dopamine receptor in cellular and organismal functionPsychopharmacology, 1998
- Dopamine Receptors: From Structure to FunctionPhysiological Reviews, 1998
- Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into SchizophreniaNeuropsychopharmacology, 1997
- Dopamine receptors: Studies on structure and function1996
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990